Cargando…

Insulin resistance in the brain: A new therapeutic target for Alzheimer's disease

Detalles Bibliográficos
Autor principal:	Umegaki, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley-Blackwell 2013
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019267/ https://www.ncbi.nlm.nih.gov/pubmed/24843644 http://dx.doi.org/10.1111/jdi.12027

Ejemplares similares

Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease
por: de la Monte, Suzanne M
Publicado: (2012)

Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease
por: Waragai, Masaaki, et al.
Publicado: (2020)

Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?
por: Heinecke, Jay W., et al.
Publicado: (2014)

Aducanumab: a new phase in therapeutic development for Alzheimer’s disease?
por: Lalli, Giovanna, et al.
Publicado: (2021)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013)

Diabetes‐related cognitive dysfunction: Hyperglycemia in the early stage might be a key?
por: Umegaki, Hiroyuki
Publicado: (2018)

Sarcopenia and diabetes: Hyperglycemia is a risk factor for age-associated muscle mass and functional reduction
por: Umegaki, Hiroyuki
Publicado: (2015)

Endothelium-Derived Hyperpolarizing Factors: A Potential Therapeutic Target for Vascular Dysfunction in Obesity and Insulin Resistance
por: Jia, Guanghong, et al.
Publicado: (2016)

Brain insulin resistance in Alzheimer’s disease
Publicado: (2012)

Targeting Ceramide Synthesis to Reverse Insulin Resistance
por: Schmitz-Peiffer, Carsten
Publicado: (2010)

LncRNAs in Adipose Tissue from Obese and Insulin-Resistant Subjects: New Targets for Therapy?
por: Latorre, Jèssica, et al.
Publicado: (2018)

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
por: Vinuesa, Angeles, et al.
Publicado: (2021)

Viewing the Brain Through Retina: A New Avenue for Early Diagnosis of Alzheimer’s Disease
por: Zuhair, Varisha, et al.
Publicado: (2023)

Alzheimer's disease therapeutic research: the path forward
por: Aisen, Paul S
Publicado: (2009)

New targets for new therapeutic approaches
por: François, Bruno
Publicado: (2014)

Targeting CITED2 for Angiogenesis in Obesity and Insulin Resistance
por: Jia, Guanghong, et al.
Publicado: (2016)

Unraveling the Paradox of Selective Insulin Resistance in the Liver: the Brain–Liver Connection
por: Ferris, Heather A., et al.
Publicado: (2016)

Care for Alzheimer's Disease
por: Umegaki, Hiroyuki, et al.
Publicado: (2013)

Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
por: Benedict, Christian, et al.
Publicado: (2018)

Mechanisms linking brain insulin resistance to Alzheimer's disease
por: Matioli, Maria Niures P.S., et al.
Publicado: (2015)

Glucocorticoid Receptor Antagonism as a New “Remedy” for Insulin Resistance—Not There Yet!
por: Varlamov, Elena V, et al.
Publicado: (2021)

Disruption of blood-brain barrier in Alzheimer disease pathogenesis
por: Kook, Sun-Young, et al.
Publicado: (2013)

New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc
por: Corona, C, et al.
Publicado: (2011)

The New Criteria for Alzheimer’s Disease - Implications for Geriatricians(*)
por: Molin, Pierre, et al.
Publicado: (2016)

Insulin and Insulin Resistance in Alzheimer’s Disease
por: Sędzikowska, Aleksandra, et al.
Publicado: (2021)

The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits
por: Mohanta, Sarajo Kumar, et al.
Publicado: (2022)

Perispinal etanercept: Potential as an Alzheimer therapeutic
por: Griffin, W Sue T
Publicado: (2008)

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
por: Yarchoan, Mark, et al.
Publicado: (2014)

New insights into adipose tissue VEGF-A actions in the control of obesity and insulin resistance
por: Elias, Ivet, et al.
Publicado: (2013)

Herbal therapy: a new pathway for the treatment of Alzheimer's disease
por: Tian, Jinzhou, et al.
Publicado: (2010)

Hydrogel: A Promising New Technique for Treating Alzheimer’s Disease
por: Gong, Baofeng, et al.
Publicado: (2022)

Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

Microvascular Contributions to Insulin Resistance
por: Rattigan, Stephen, et al.
Publicado: (2013)

Can gamma entrainment of the brain rhythms prevent or alleviate Alzheimer’s disease?
por: Kim, Tae
Publicado: (2021)

The Potential Role of the Brain–gut Axis in the Development and Progression of Alzheimer's Disease
por: Zhou, Guisheng, et al.
Publicado: (2022)

Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
por: Nowell, Joseph, et al.
Publicado: (2022)

Is Insulin Action in the Brain Clinically Relevant?
por: Filippi, Beatrice M., et al.
Publicado: (2012)

Insulin Resistance in Alzheimer's Disease
por: Ferreira, Laís S. S., et al.
Publicado: (2018)

Pathophysiology and new targets for therapeutic options in Chagas heart disease
por: Ferreira, João Marcos B Barbosa
Publicado: (2022)

Phosphatidylserine trapped in the net: A new therapeutic target for the ischemic stroke?
por: Rodriguez Lucci, Federico, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b9pff4kovf8rukpnar3enh9fjk